Abstract
A 4.6 kg infant with Wiskott-Aldrich syndrome received an accidental overdose of busulfan during preparation for allogeneic stem cell transplantation. Pharmacokinetic analysis of plasma busulfan levels alerted staff to the dosing error. Hemodialysis was immediately performed and resulted in accelerated clearance of busulfan. There were no acute neurologic and hepatic side-effects of the busulfan overdose, and despite 2 months of cough accompanied by rales, the patient is now free of pulmonary symptoms. Stable partial donor chimerism occurred after transplantation. At present, the patient is thriving and infection-free 12 months after transplantation, although his platelet count remains at the lower limit of normal. Bone Marrow Transplantation (2001) 27, 551–553.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dix SP, Wingard JR, Mullins RE et al. Association of busulfan area under the curve with veno-occlusive disease following BMT Bone Marrow Transplant 1996 17: 225–230
Li CK, Yuen PM, Wong R et al. Busulfan level and early mortality in thalassemia patients after BMT Bone Marrow Transplant 1999 23: 307–310
Caculow Ska AB, Blazar BR, Angeluchi E et al. Relationship of plasma pharmacokinase of high-dose oral busulfan to the outcome of BMT in children with thalassemia Bone Marrow Transplant 1997 20: 915–920
Ehrsson H, Hassan M . Binding of busulfan to plasma proteins and blood cells J Pharm Pharmacol 1984 36: 694–696
Mazuazi N, Higa T, Nakagawa S et al. Pharmacokinetic study of busulfan in an AML patient treated with regular hemodialysis Ann Hematol 1998 77: 293–294
Ullery L, Gibbs J, Ames G et al. Busulfan clearance in renal failure and hemodialysis Bone Marrow Transplant 2000 25: 925–930
Shaw P, Scharping C, Brian R et al. Busulfan pharmacokinetics using single daily high dose regimen in children with acute leukemia Blood 1994 87: 2357–2362
Santos G, Tutschka P, Brookmeyer R et al. Marrow transplantation for acute non-lymphocytic leukemia after treatment with busulfan and cyclophosphamide New Eng J Med 1983 309: 1347–1353
Chen CS, Sendel K, Armitage J et al. Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society of Blood and Bone Marrow Transplantation Biol Blood Bone Marrow Transplant 1997 3: 331–340
Zernikow B, Michel E, Fleishback G, Bode U . Accidental iatrogenic intoxications by cytotoxic drugs Drug Safety 1999 21: 57–74
Acknowledgements
The authors are indebted to Prof JT Slattery from the Fred Hutchinson Center of Cancer Research (Seattle, WA, USA) for his valuable advice.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stein, J., Davidovitz, M., Yaniv, I. et al. Accidental busulfan overdose: enhanced drug clearance with hemodialysis in a child with Wiskott-Aldrich syndrome. Bone Marrow Transplant 27, 551–553 (2001). https://doi.org/10.1038/sj.bmt.1702801
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702801
Keywords
This article is cited by
-
Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation
Bone Marrow Transplantation (2010)
-
Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population: a comparative study between the standard 4-dose and a 2-dose regimen
Bone Marrow Transplantation (2008)
-
Accidental busulfan overdose during conditioning for stem cell transplantation
Bone Marrow Transplantation (2005)